Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Proto Labs (NYSE:PRLB - Get Rating) had its price objective lowered by equities researchers at Craig Hallum to $42.00 in a note issued to investors on Tuesday, Stock Target Advisor reports. Craig Hallum's price objective would indicate a potential downside of 5.58% from the company's previous close.
Separately, StockNews.com raised Proto Labs from a "hold" rating to a "buy" rating in a research note on Monday.Proto Labs Stock Performance
Shares of NYSE PRLB traded down $2.10 during trading hours on Tuesday, hitting $44.48. The stock had a trading volume of 4,160 shares, compared to its average volume of 140,233. The company has a market capitalization of $1.22 billion, a P/E ratio of 50.70 and a beta of 1.28. The firm's 50-day moving average price is $47.77 and its two-hundred day moving average price is $49.09. Proto Labs has a 52 week low of $39.36 and a 52 week high of $82.98.
Proto Labs (NYSE:PRLB - Get Rating) last announced its quarterly earnings results on Friday, August 5th. The industrial products company reported $0.46 EPS for the quarter, beating the consensus estimate of $0.39 by $0.07. The business had revenue of $126.90 million during the quarter, compared to analysts' expectations of $127.28 million. Proto Labs had a return on equity of 2.95% and a net margin of 4.88%. The firm's quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.47 EPS. As a group, analysts expect that Proto Labs will post 0.63 EPS for the current fiscal year. Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the business. Vanguard Group Inc. increased its position in shares of Proto Labs by 5.1% during the first quarter. Vanguard Group Inc. now owns 2,848,640 shares of the industrial products company's stock valued at $150,693,000 after purchasing an additional 137,885 shares during the period. Disciplined Growth Investors Inc. MN increased its position in shares of Proto Labs by 3.9% during the first quarter. Disciplined Growth Investors Inc. MN now owns 1,860,976 shares of the industrial products company's stock valued at $98,446,000 after purchasing an additional 69,043 shares during the period. Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of Proto Labs by 11.6% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,076,037 shares of the industrial products company's stock valued at $51,478,000 after purchasing an additional 111,440 shares during the period. Nikko Asset Management Americas Inc. increased its position in shares of Proto Labs by 11.6% during the second quarter. Nikko Asset Management Americas Inc. now owns 1,076,037 shares of the industrial products company's stock valued at $43,041,000 after purchasing an additional 111,440 shares during the period. Finally, State Street Corp increased its position in shares of Proto Labs by 3.7% during the first quarter. State Street Corp now owns 1,035,329 shares of the industrial products company's stock valued at $54,769,000 after purchasing an additional 37,314 shares during the period. 93.35% of the stock is currently owned by institutional investors and hedge funds. Proto Labs Company Profile (Get Rating)
Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts.Featured ArticlesGet a free copy of the StockNews.com research report on Proto Labs (PRLB)Are Medtronic And Intuitive Surgical Poised For Big Growth? Ralph Lauren Is A Retail Stock You Can Buy And HoldInsider Sales At Cloudflare Are No Worry For Investors Home Depot, Lowe's On Track To Grow 2022 Earnings Could Smaller be Better for Investors in Norwegian Cruise Lines?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Proto Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.
While Proto Labs currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:
What investors can learn from studying the past, as well as offering some ideas about asset classes with future potential.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.